Letters Pandemic flu

Look at all the evidence before stockpiling amantadine

BMJ 2007; 334 doi: http://dx.doi.org/10.1136/bmj.39136.489942.FA (Published 01 March 2007) Cite this as: BMJ 2007;334:439
  1. Tom Jefferson, Cochrane Acute Respiratory Infections Group
  1. Anguillara Sabazia, Rome 00061, Italy
  1. jefferson.tom{at}gmail.com

    Tsiodras et al propose testing amantadine to see if any benefits could accrue in combination with neuraminidase inhibitors in pandemic flu.1 The principal attraction seems to be low cost. Although they quote resistance and harms as well as lack of “any demonstrable reduction in transmissibility or pathogenicity,” this does not seem to deter them from their proposal.

    Had they consulted the Cochrane Library, they …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe